Personalized Diagnostics

Podcast by Joseph Anderson, MD

englanti

Teknologia & tieteet

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi.Peru milloin tahansa.

Podimon podcastit
Lataa offline-käyttöön

Aloita maksutta

Lisää Personalized Diagnostics

Welcome to the Personalized Diagnostics Podcast. We are going to be talking to some of the greatest minds and personalities in the diagnostics space – the engine which is driving personalized medicine forward. We will be exploring the unmet need for better diagnostics across the patient journey - from screening to treatment to treatment monitoring, new assay development, technologies such as next generation sequencing and artificial intelligence plus we’ll be tackling issues in reimbursement and health economics- how we’re going to pay for all this and how diagnostics can provide value to the health care system. Thanks for listening.

Kaikki jaksot

80 jaksot

Jeffery Taubenberger, MD, PhD, of the NIH, Sequencing the 1918 Spanish Flu and What do we know About the Novel Coronavirus? - Episode 20

What can we learn from previous pandemics to apply to the current situation? What do we actually know to be true about the novel coronavirus? Jeffrey Taubenberger, MD, PhD, a physician-scientist and investigator at the National Institutes of Health, joins us to discuss his landmark work in sequencing the 1918 Spanish flu virus and to provide insights into the current novel coronavirus global pandemic.

12. heinä 2020 - 31 min

BRUNO LARVOL, FOUNDER AND CEO OF LARVOL - PREVIEW 3

Change can be slow - particularly in #healthcare. Establishing clinical validity and clinical utility can be slow. Getting regulatory approvals can be slow. Gaining payor acceptance can be slow.

12. heinä 2020 - 43 s

Bruno Larvol, Founder and CEO of Larvol - Preview 2

Where are we in this megatrend of precision #medicine?

12. heinä 2020 - 2 min

Bruno Larvol, Founder and CEO of Larvol - Preview 1

Since the human genome has been sequenced, it has become clear that the technology to sequence has far outstripped our capabilities to accurately classify and interpret genetic variants. It turns out that genetic variants are much more common than we ever suspected and many - in some cases most - variants are of uncertain significance. But is the attempt to accurately classify Variants of Uncertain Significance (VUS) a losing strategy?

12. heinä 2020 - 1 min

Bruno Larvol, Founder and CEO of the Healthcare Data Company, Larvol - Episode 19

We have seen tremendous advances in sequencing technology. And the cost to sequence is going to zero, according to Moore's Law. More and more genes and gene sets are being correlated with clinical outcome and response to therapy. Is bioinformatics intelligence the missing link to realizing the promise of precision medicine? Will a company emerge as the Google or Amazon of cancer informatics? Our guest is Bruno Larvol, of the eponymous healthcare data company, Larvol.

22. kesä 2020 - 34 min

Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää

Kiva sovellus podcastien kuunteluun, ja sisältö on monipuolista ja kiinnostavaa

Todella kiva äppi, helppo käyttää ja paljon podcasteja, joita en tiennyt ennestään.

Valitse tilauksesi

Suosituimmat

Premium